Ana Tediosi | Head of Expanded Access Program Strategy
WEP Clinical

With over 10 years of experience in the pharmaceutical industry, Ana is a recognized expert in the field of Expanded Access Programs (EAP). Her expertise lies in oncology, hematology, Rare Diseases, and she has held various roles in the big Pharma (Roche, Menarini-Stemline), including leading asset transitions, commercial project lead, PV& compliance. Throughout her career, Ana has consistently demonstrated strong communication skills and a proven track record of successfully driving projects in challenging and international environments. Her commitment to delivering the best healthcare solutions to patients is unwavering, and she is equally passionate about promoting gender equality in both business and society. Ana is currently based in Switzerland working as a Business Development Director and Head of Expanded Access Strategy at WEP Clinical